Quantum BioPharma Ltd. (QNTM)
NASDAQ: QNTM · Real-Time Price · USD
3.120
-0.050 (-1.58%)
Apr 17, 2026, 4:00 PM EDT - Market closed
Quantum BioPharma Market Cap
Quantum BioPharma has a market cap or net worth of $18.46 million as of April 17, 2026. Its market cap has decreased by -19.91% in one year.
Market Cap
18.46M
Enterprise Value
16.15M
1-Year Change
-19.91%
Ranking
Category
Stock Price
$3.12
Market Cap Chart
Since May 29, 2018, Quantum BioPharma's market cap has decreased from $121.65M to $18.46M, a decrease of -84.82%. That is a compound annual growth rate of -21.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 18.46M | -37.13% |
| Dec 31, 2025 | 29.37M | 321.68% |
| Dec 31, 2024 | 6.96M | -80.54% |
| Dec 29, 2023 | 35.78M | 20.93% |
| Dec 30, 2022 | 29.59M | -29.85% |
| Dec 31, 2021 | 42.18M | 40.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| VYNE Therapeutics | 20.58M |
| Allarity Therapeutics | 19.62M |
| Polyrizon | 19.50M |
| Citius Pharmaceuticals | 19.13M |
| Lipocine | 18.69M |
| Pasithea Therapeutics | 18.36M |
| OSR Holdings | 18.25M |
| Genenta Science | 17.05M |